NCT00879996

Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients

A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 54 (actual)
• Sponsor: State University of New York at Buffalo · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine if buprenorphine or methadone is better for the treatment of chronic pain among patients who have become addicted to prescription narcotics.

Detailed description

The purpose of this randomized clinical trial is to compare methadone with buprenorphine for the treatment of chronic pain among patients who have developed a physical dependence on prescription opiate analgesics that is associated with psychosocial dysfunction (i.e., addiction).

Conditions

• Opiate Addiction

Interventions

Type	Name	Description
DRUG	Methadone	Oral, 10-60 mg per day, 2-4 times per day, 6 months
DRUG	Buprenorphine/naloxone	Sub-lingual, 4-16 mg per day, divided 2-4 times/day, 6 months

Timeline

• Start date: 2009-04-01
• Primary completion: 2011-10-01
• Completion: 2011-10-01
• First posted: 2009-04-13
• Last updated: 2012-08-07
• Results posted: 2012-07-09

Locations

2 sites across 1 country: United States